|Bid||128.28 x 800|
|Ask||128.34 x 800|
|Day's range||127.58 - 129.39|
|52-week range||100.39 - 135.05|
|Beta (5Y monthly)||1.02|
|PE ratio (TTM)||93.17|
|Earnings date||01 May 2023 - 05 May 2023|
|Forward dividend & yield||0.96 (0.74%)|
|Ex-dividend date||23 Dec 2022|
|1y target est||131.27|
Strong growth in EVO ICL units led by increased market adoption is likely to have driven STAAR Surgical's (STAA) Q4 revenues.
Each of Zimmer Biomet's (ZBH) geographic segments and product divisions record year-over-year sales growth at CER.
Zimmer (ZBH) delivered earnings and revenue surprises of 2.73% and 3.59%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?